Ad-TD-nsIL12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ad-TD-nsIL12, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma [Phase 1, Phase 2]